Adding C‐reactive protein and procalcitonin to the model of end‐stage liver disease score improves mortality prediction in patients with complications of cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|33|3|726-732

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.3, 2018-03, pp. : 726-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C‐reactive protein and model for end‐stage liver disease score: Have we found the fifth element?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 713-715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reciprocal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease – A Follow-Up Study

By  

Nephron Clin Pract, Vol. 101, Iss. 1, 2005-05 ,pp. : c18-c24

Karger

Access to resources Recommend Favorite

MELDEQ: An alternative Model for End‐Stage Liver Disease score for patients with hepatocellular carcinoma

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 5, 2015-05 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1643-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end‐stage liver disease score era

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 9, 2015-09 ,pp. : 1160-1168

John Wiley & Sons Inc

Access to resources Recommend Favorite